Pilonidal sinus disease: an intergluteal localization of hidradenitis suppurativa/acne inversa: a cross-sectional study among 2465 patients.
Por:
Benhadou F, Van der Zee HH, Pascual J, Rigopoulos D, Katoulis A, Liakou AI, Daxhelet M, Romanelli M, Iannone M, Kinyó Á, Nikolakis G, Zouboulis CC, Dessinioti C, Zisimou C, Antoniou C, Alavi A, Mintoff D, Aquilina S, Matusiak L, Szepietowski JC, Sinclair R, Husein-ElAhmed H, von Laffert M, Revuz J, Danby B, Puig L, Theut Riis P, Jemec GBE, van Straalen K, Wigny KMGJ, Del Marmol V and Guillem P
Publicada:
1 dic 2019
Ahead of Print:
27 mar 2019
Resumen:
Hidradenitis suppurativa (HS), also referred to as acne inversa, is a debilitating skin disease characterized by inflammatory nodules, chronic abscesses and tunnels (fistulae and sinuses). The association with pilonidal sinus disease (PSD) is frequently reported but not well documented.
Filiaciones:
Benhadou F:
Department of Dermatology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
ResoVerneuil, Paris, France
European Hidradenitis Suppurativa Foundation e.V, Europe
Van der Zee HH:
European Hidradenitis Suppurativa Foundation e.V, Europe
Department of Dermatology, Erasmus University Medical Center, Rotterdam, Netherlands
Pascual J:
European Hidradenitis Suppurativa Foundation e.V, Europe
Department of Dermatology, Alicante University General Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Alicante, Spain
Rigopoulos D:
2nd Department of Dermatology and Venereology, 'Attikon' General University Hospital, National and Kapodistrian University of Athens, Athens, Greece
Katoulis A:
European Hidradenitis Suppurativa Foundation e.V, Europe
2nd Department of Dermatology and Venereology, 'Attikon' General University Hospital, National and Kapodistrian University of Athens, Athens, Greece
Liakou AI:
European Hidradenitis Suppurativa Foundation e.V, Europe
2nd Department of Dermatology and Venereology, 'Attikon' General University Hospital, National and Kapodistrian University of Athens, Athens, Greece
Daxhelet M:
Department of Dermatology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
European Hidradenitis Suppurativa Foundation e.V, Europe
Romanelli M:
European Hidradenitis Suppurativa Foundation e.V, Europe
Department of Dermatology, University of Pisa, Pisa, Italy
Iannone M:
Department of Dermatology, University of Pisa, Pisa, Italy
Kinyó Á:
European Hidradenitis Suppurativa Foundation e.V, Europe
Department of Dermatology, Venereology and Oncodermatology, University of Pécs, Medical School, Pécs, Hungary
Nikolakis G:
European Hidradenitis Suppurativa Foundation e.V, Europe
Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical School Theodore Fontane, Dessau, Germany
Zouboulis CC:
European Hidradenitis Suppurativa Foundation e.V, Europe
Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical School Theodore Fontane, Dessau, Germany
Dessinioti C:
European Hidradenitis Suppurativa Foundation e.V, Europe
Department of Dermatology, Andreas Syggros Hospital, Athens, Greece
Zisimou C:
European Hidradenitis Suppurativa Foundation e.V, Europe
Department of Dermatology, Andreas Syggros Hospital, Athens, Greece
Antoniou C:
European Hidradenitis Suppurativa Foundation e.V, Europe
Department of Dermatology, Andreas Syggros Hospital, Athens, Greece
Alavi A:
European Hidradenitis Suppurativa Foundation e.V, Europe
Department of Dermatology, York Dermatology Center, Richmond Hill, United States
Mintoff D:
European Hidradenitis Suppurativa Foundation e.V, Europe
Department of Dermatology, Sir Paul Boffa Hospital, Floriana, Malta
Aquilina S:
European Hidradenitis Suppurativa Foundation e.V, Europe
Department of Dermatology, Sir Paul Boffa Hospital, Floriana, Malta
Matusiak L:
European Hidradenitis Suppurativa Foundation e.V, Europe
Department of Dermatology, Allergology and Venereology, Wroclaw Medical University, Wroclaw, Poland
Szepietowski JC:
European Hidradenitis Suppurativa Foundation e.V, Europe
Department of Dermatology, Allergology and Venereology, Wroclaw Medical University, Wroclaw, Poland
Sinclair R:
European Hidradenitis Suppurativa Foundation e.V, Europe
Department of Dermatology, Epworth Hospital, University of Melbourne, Melbourne, Australia
Husein-ElAhmed H:
Department of Dermatology, Hospital de Baza, Granada, Spain
von Laffert M:
European Hidradenitis Suppurativa Foundation e.V, Europe
Institute of Pathology, Charité-Universitaetsmedizin Berlin, Berlin, Germany
Revuz J:
European Hidradenitis Suppurativa Foundation e.V, Europe
Private practiceFrance
Danby B:
European Hidradenitis Suppurativa Foundation e.V, Europe
Department of Dermatology, Geisel School of Medicine at Dartmouth, Manchester, United States
Puig L:
European Hidradenitis Suppurativa Foundation e.V, Europe
Hospital de la Santa Creu i Sant Pau
Autonomous University of Barcelona, Barcelona, Spain
Theut Riis P:
European Hidradenitis Suppurativa Foundation e.V, Europe
Department of Dermatology, Zealand University Hospital, Health Sciences Faculty, University of Copenhagen, Denmark
Jemec GBE:
European Hidradenitis Suppurativa Foundation e.V, Europe
Department of Dermatology, Zealand University Hospital, Health Sciences Faculty, University of Copenhagen, Denmark
van Straalen K:
European Hidradenitis Suppurativa Foundation e.V, Europe
Department of Dermatology, Erasmus University Medical Center, Rotterdam, Netherlands
Wigny KMGJ:
Department of Dermatology, Erasmus University Medical Center, Rotterdam, Netherlands
Del Marmol V:
Department of Dermatology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
European Hidradenitis Suppurativa Foundation e.V, Europe
Guillem P:
ResoVerneuil, Paris, France
European Hidradenitis Suppurativa Foundation e.V, Europe
Department of Surgery, Clinique du Val d'Ouest, Ecully, France
|